2018 has only 40 something days to go, now we are not expecting the Partnership agreement with big pharmas will occur this year.
However there are still 2 major events should (according to management's schedule) come out any day anytime before the year end.
1. Toxic study result for both indications of LOXL2.
2. FDA submitting of Bronchitol(if the Italian Pharma really want to do).
Whilst the positive announcement last week again failed to move the share price, I am interested and eager to see if these remain 2 events can do some heavy-lifting.
PXS Price at posting:
26.5¢ Sentiment: None Disclosure: Held
